Literature DB >> 28285450

Computed tomography guided navigation assisted percutaneous ablation of osteoid osteoma in a 7-year-old patient: the low dose approach.

Miltiadis Krokidis1, Carlo Tappero2, Daniel Bogdanovic2, Kai Ziebarth3, Anna-Christina Stamm2.   

Abstract

Osteoid osteoma (OO) is a benign tumour that can cause severe pain and functional limitation to children and young adults; the treatment of choice is image-guided ablation. Due to the very small size of the lesion, detection and accurate needle placement may be challenging. Computed tomography (CT) offers very detailed imaging of the skeleton and is the modality of choice for the detection of small OO and for ablation guidance. Nevertheless, CT-guided positioning of the ablation applicator is linked to significant radiation exposure, particularly for the paediatric population. This case describes the successful use of a novel CT-based navigation system that offers the possibility of accurate ablation with only minimal radiation exposure in a paediatric patient.

Entities:  

Keywords:  ALARA; Ablation; CT-navigation systems; Osteoid osteoma; Radiation exposure

Mesh:

Year:  2017        PMID: 28285450     DOI: 10.1007/s00256-017-2620-y

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  13 in total

1.  Technical considerations in CT-guided radiofrequency thermal ablation of osteoid osteoma: tricks of the trade.

Authors:  Clinton H Pinto; Anthonie H M Taminiau; Geert M Vanderschueren; Pancras C W Hogendoorn; Johan L Bloem; Willem R Obermann
Journal:  AJR Am J Roentgenol       Date:  2002-12       Impact factor: 3.959

2.  Low radiation dose CT technique for guidance of radiofrequency ablation of osteoid osteoma.

Authors:  C P Cantwell; P Kenny; S Eustace
Journal:  Clin Radiol       Date:  2008-02-21       Impact factor: 2.350

3.  Percutaneous Biopsy and Radiofrequency Ablation of Osteoid Osteoma with Excess Reactive New Bone Formation and Cortical Thickening Using a Battery-Powered Drill for Access: A Technical Note.

Authors:  D Filippiadis; C Gkizas; C Kostantos; A Mazioti; L Reppas; E Brountzos; N Kelekis; A Kelekis
Journal:  Cardiovasc Intervent Radiol       Date:  2016-05-26       Impact factor: 2.740

4.  Osteoid osteoma: CT-guided percutaneous radiofrequency ablation and follow-up in 47 patients.

Authors:  K Woertler; T Vestring; F Boettner; W Winkelmann; W Heindel; N Lindner
Journal:  J Vasc Interv Radiol       Date:  2001-06       Impact factor: 3.464

5.  Radiofrequency thermoablation of primary non-spinal osteoid osteoma: optimization of the procedure.

Authors:  E Rimondi; Giuseppe Bianchi; M C Malaguti; R Ciminari; A Del Baldo; M Mercuri; U Albisinni
Journal:  Eur Radiol       Date:  2005-03-09       Impact factor: 5.315

6.  Radiation dosimetry of intraoperative cone-beam compared with conventional CT for radiofrequency ablation of osteoid osteoma.

Authors:  Edward Y Cheng; Sameer M Naranje; E Russell Ritenour
Journal:  J Bone Joint Surg Am       Date:  2014-05-07       Impact factor: 5.284

7.  Nondiaphyseal osteoid osteomas in the pediatric patient.

Authors:  R S Davidson; S Mahboubi; S Heyman; D S Drummond
Journal:  Clin Orthop Relat Res       Date:  1989-06       Impact factor: 4.176

8.  Osteoid osteoma: percutaneous treatment with radiofrequency energy.

Authors:  Daniel I Rosenthal; Francis J Hornicek; Martin Torriani; Mark C Gebhardt; Henry J Mankin
Journal:  Radiology       Date:  2003-08-27       Impact factor: 11.105

9.  Percutaneous radiofrequency ablation of osteoid osteomas with use of real-time needle guidance for accurate needle placement: a pilot study.

Authors:  Wendy M H Busser; Yvonne L Hoogeveen; Rene P H Veth; H W Bart Schreuder; Angelique Balguid; W KlaasJan Renema; Leo J Schultzekool
Journal:  Cardiovasc Intervent Radiol       Date:  2010-07-29       Impact factor: 2.740

10.  Stereotactically-navigated percutaneous Irreversible Electroporation (IRE) compared to conventional IRE: a prospective trial.

Authors:  Lukas P Beyer; Benedikt Pregler; Christoph Nießen; Andreas Schicho; Michael Haimerl; Ernst Michael Jung; Christian Stroszczynski; Philipp Wiggermann
Journal:  PeerJ       Date:  2016-08-11       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.